News
PHG
19.98
0.00%
0.00
Inspire Medical rebounds as J.P. Morgan defends after Lilly sleep data
Seeking Alpha · 3d ago
Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder
Seeking Alpha · 3d ago
Weekly Report: what happened at PHG last week (0408-0412)?
Weekly Report · 5d ago
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 5d ago
Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities
Seeking Alpha · 04/13 09:03
UPDATE 1-Agnellis' Exor targets growth in healthcare sector
Agnellis' Exor targets growth in healthcare sector. Has already invested almost 4 billion euros in healthcare. Has cash firepower of 1.7 bln euros already allocated. To receive around 1.1 bln euro in dividends during 2024. Exor is the investment arm of the Agnelli family.
Reuters · 04/11 09:35
Exor has growing interest in healthcare industry
Exor has growing interest in the healthcare industry. The investment arm of the Agnelli family has already invested almost 4 billion euros in the industry. Exor views healthcare as a "long-term, structural growth sector" Exor's investments cover a broad range of industries.
Reuters · 04/11 08:43
Mizuho sees ResMed as "overwhelming beneficiary" of Philips consent decree
Mizuho sees ResMed as "overwhelming beneficiary" of Philips consent decree. ResMed is positioned to retain more than $450M in US market share gains for "much longer" than anticipated. Mizuho has a buy rating on ResMed with a price target of $215.
Seeking Alpha · 04/10 19:46
Trending: Philips in Final Agreement With DOJ, FDA on Ventilators
Philips is one of the most mentioned companies in the U.S. Across all news items in the last 12 hours. The company reached a final agreement with the Justice Department and FDA on a settlement related to ventilators. Philips is required to stop manufacturing most sleep and respiratory devices in Pennsylvania.
Dow Jones · 04/10 18:12
Why Is European Healthcare Tech Giant Philips Stock Trading Higher On Wednesday?
Philips reached a final agreement with the U.S. Justice Department and FDA regarding a settlement related to Respironics ventilators. The company said it will continue to prioritize the remediation of the sleep and respiratory care devices. The agreement primarily focuses on the company's business operations in the United States.
Benzinga · 04/10 13:47
Health Care Sector Update for 04/10/2024: PHG, CVS, CNC, XLV, IBB
NASDAQ · 04/10 13:17
Stocks to Watch Wednesday: Delta Air Lines, Alibaba, XPeng, Microsoft
Delta Air Lines reported record revenues for the first quarter. Shares of the e-commerce giant Alibaba rallied in Hong Kong and premarket in the U.S. Microsoft will bring its Blizzard game titles back to China. Royal Philips reached a settlement with authorities on a settlement over its ventilators.
The Wall Street Journal · 04/10 10:51
Wall Street Breakfast Podcast: Intel Unveils New AI Chip, Setting Up Race With Nvidia
Wall Street Breakfast Podcast: Intel Unveils New AI Chip, Setting Up Race With Nvidia. Costco may be sitting on gold with its new precious metals business. Philips reaches a final agreement with the DOJ and FDA on a consent decree related to its sleep apnea devices.
Seeking Alpha · 04/10 10:50
UPDATE 1-Philips shares rise on final US deal on sleep apnea machines
Philips shares rise on final US deal on sleep apnea machines. The company reached an agreement in January with the U.S. Government on its machines. It has already cost the company over 360 million euros in the fourth quarter of 2023. The agreement followed the recall of millions of breathing devices and ventilators.
Reuters · 04/10 09:49
UPDATE 2-Europe's STOXX 600 drops to one-month low after hot U.S. inflation data
Europe's STOXX 600 drops to one-month low after hot U.S. Inflation data. US consumer prices rise more than expected in March, pushing back expectations for interest rate cut. Real estate and financials lead declines in European shares. The pan-continent index lost 0.6% after the data.
Reuters · 04/10 08:57
Stocks to Watch Wednesday: Microsoft, Boeing, Delta Air Lines
Microsoft says it will bring its Blizzard game titles back to China. Boeing is accused of dismissing quality and safety concerns during production of its troubled 787 Dreamliner jets. Taiwan Semiconductor Manufacturing Co. Said revenue in March rose 34% from a year ago. Royal Philips and Delta Air Lines are set to report results this morning.
The Wall Street Journal · 04/10 08:54
Philips reaches agreement with DOJ, FDA on consent decree over sleep apnea devices
Healthcare Philips reaches agreement with DOJ, FDA on consent decree over sleep apnea devices. Philips recalled millions of breathing devices and ventilators used to treat sleep Apnea in 2021. The company will not resume selling new respiratory care devices in the U.S. Until the consent decree is met.
Seeking Alpha · 04/10 08:22
BUZZ-Philips up on U.S. consent decree for sleep apnea machines
Philips agrees with the U.S. Government on a consent decree about the sales of its sleep apnea machines. Shares in Philips jump 3% after the announcement. Dutch health technology company says its financial outlook remains unchanged after the consent decree. The stock has dropped more than 6% year-to-date.
Reuters · 04/10 07:36
Philips shares climb after finalizing pact with U.S. over device sales
MarketWatch · 04/10 07:30
More
Webull provides a variety of real-time PHG stock news. You can receive the latest news about Koninklijke Phil through multiple platforms. This information may help you make smarter investment decisions.
About PHG
Koninklijke Philips NV is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.